HighLife Medical
PrivateLast Round
Early Funding
Sep 22, 2026
Total Funding Raised
$140.27M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
HighLife Medical is a medical technology company that develops transcatheter mitral valve replacement (TMVR) systems for patients with mitral regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HighLife Medical Comparables
Compare HighLife Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InnovHeart | 89% | |
| Polares Medical | 88% | |
| ReValve Solutions | 87% |
HighLife Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 22, 2026 | ||||
| Series B Extension | Dec 11, 2020 | ||||
| Series B | Jan 17, 2019 | ||||
| Series A | Oct 30, 2017 |
HighLife Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capricorn Partners | Early Funding |
| BNP Paribas Développement | Early Funding |
| Andera Partners | Series B, Early Funding |
| Critical Path Ventures | Early Funding |
| VI Partners | Early Funding, Series B Extension |
| U.S. Venture Partners | Early Funding, Series B |
| Rives Croissance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
$90M raised from Andera Partners, BNP Paribas, and others.
- Aug 21, 2026
Monthly visitors grew 31% MoM, reaching 1.9K.
Recent news
Latest coverage and updates
- receives_financingSep 22, 2026
On Sep 22nd '26 in France, HighLife SAS announced the successful completion of a $90M financing round co-led by Andera Partners, Sofinnova Partners, Supernova Invest and Mérieux Equity Partners to accelerate commercial expansion in Europe and advance its US clinical development program.
HighLife Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HighLife Medical's valuation, stock price, and market status.
Is HighLife Medical a public or private company?
HighLife Medical is a private company.
What is the current stock price of HighLife Medical?
HighLife Medical is a private company, so its shares have no public market price. Caplight tracks HighLife Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HighLife Medical worth (valuation)?
Valuation information for HighLife Medical is not publicly available.
Can I buy HighLife Medical stock?
HighLife Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HighLife Medical's last funding round?
HighLife Medical's most recent funding round was Early Funding on September 22, 2026.
Who are the main investors in HighLife Medical?
Key investors in HighLife Medical include Andera Partners, VI Partners, U.S. Venture Partners, Sofinnova Partners.
Will HighLife Medical IPO soon?
No public IPO plans have been announced for HighLife Medical.
How can I track HighLife Medical secondary market activity?
Caplight tracks bids, offers, and trades in HighLife Medical's shares on secondary markets.